Loading viewer...
earnings
Format: PDF earnings
Q1 2023 earnings presentation with sales of $266.0M representing 45.5% organic year-over-year growth. Gross profit margin of 29.0% increased 380 basis points year-over-year, EBITDA reached $54.6M with a 20.5% margin, and diluted EPS doubled to $0.67. Backlog grew 30.0% year-over-year to $599.9M.
investor_presentation
18 Pages
earnings
40 Pages
DuPont
Coca-Cola Q2 2021 Investor Presentation
earningsearnings
45 Pages
The Coca-Cola Company
Albemarle Q2 2016 Earnings Call
earningsearnings
17 Pages
Albemarle Corporation
Amphastar Pharmaceuticals Q2 2016 Earnings
earningsearnings
21 Pages
Amphastar Pharmaceuticals